A frequent co-author of Ulrich Lichtenthaler — the management professor who has retracted at least eight papers — has now withdrawn one of his own from Research Policy.
The original paper, “How to create commercial value from patents: The role of patent management,” by Holger Ernst and colleagues, went online on May 21, 2012. Here’s the notice: Continue reading Lichtenthaler co-author Ernst retracts paper that didn’t include Lichtenthaler
A German professor who claims to have developed “a self-consistent field theory which is used to derive at all known interactions of the potential vortex” will have at least two papers retracted, thanks to the scrutiny of a concerned economist.
The first retraction has already appeared, in DNA and Cell Biology, for a paper by Konstantin Meyl called “DNA and Cell Resonance: Magnetic Waves Enable Cell Communication.” The notice says nothing: Continue reading “Way out there” paper claiming to merge physics and biology retracted
Annette Schavan, the German minister for education and research, has had her PhD revoked by the University of Dusseldorf following an investigation into alleged plagiarism.
Der Spiegel reports: Continue reading German education and research minister Schavan loses doctorate over plagiarism
A group of neonatologists in Germany has retracted a paper after apparently realizing that their data weren’t what they thought they were.
Here’s the notice, for “Low Dose Lidocaine for Refractory Seizures in Preterm Neonates,” which appeared in the Indian Journal of Pediatrics: Continue reading Seizure study retracted after authors realize data got “terribly mixed”
Medical and Veterinary Entomology has retracted a 2010 paper by a group of German researchers who populated the article with data from previously published studies.
The article, titled “Established and emerging pathogens in Ixodes ricinus ticks collected from birds on a conservation island in the Baltic Sea,” looked at the potential role of migrating birds in the spread of tick-borne infections such as Lyme disease and babesiosis. Here’s the abstract: Continue reading Tick-borne disease paper retracted for data reuse
Retraction Watch readers may recall the case of Silvia Bulfone-Paus, a researcher at Germany’s Research Center Borstel who was a frequent subject of posts in the early days of this blog. Bulfone-Paus has had to retract 13 papers amid investigations into allegations of image manipulation.
To briefly recap: In May 2010, several months after concerns had first been raised, Borstel let the DFG (German Research Foundation) know about the allegations, because they had funded the work. A November 2010 report from Borstel said that the allegations had merit, blaming two of Bulfone-Paus’s postdocs but criticizing how she supervised them. As the DFG notes in a summary of its findings on the case, posted late last week: Continue reading Funding agency sanctions Bulfone-Paus and former postdoc
A group of cardiology researchers formerly of the University of Cologne has retracted two papers, after investigations into allegations of misconduct led to an admission of guilt by one of the lab’s junior members.
Here’s the first retraction, for “Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes,” published last week in the Journal of Clinical Investigation: Continue reading Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation
We’re a few months late on this one, but Heart, a BMJ title, issued a fascinating retraction notice in August about a meta-analysis on percutaneous coronary intervention (that’s stenting to you and me) after suffering a heart attack, and the drug abciximab, which is used to prevent clotting and additional near-term heart attacks. Abciximab is sold as ReoPro by Eli Lilly.
The article, “Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient-data pooled analysis of randomised studies,” was published last May. But according to the retraction notice, the authors had neglected to include fresh data, already in the literature before their paper went live, that contradicted their overall findings.
Here’s the notice: Continue reading Heart retracts stent-ReoPro paper over data dispute with authors (save one)
The list of Ulrich Lichtenthaler retractions has grown to eight.
Here’s the new notice, for “Externally commercializing technology assets: An examination of different process stages,” from the Journal of Business Venturing: Continue reading What’s new is not new again: Ulrich Lichtenthaler retracts eighth paper
Ulrich Lichtenthaler, the management professor at the University of Mannheim who has already retracted six papers for statistical irregularities, has another retraction for his CV.
Here’s the notice, from Organization Science: Continue reading Retraction seven arrives for Ulrich Lichtenthaler